Shenzhen-based artificial intelligence company Malong Technologies and the University of Bern formed a partnership Friday on creating a joint laboratory to apply the advanced technology in neurological diseases.
The medical AI joint laboratory will operate both in Shenzhen and in Bern.
A joint team of scientists and researchers from the two sides will be established. They will work together on integrating AI with biomedical engineering and basic research to improve brain disease prediction, diagnosis and prognosis, and to develop new cures.
Malong Technologies and the University of Bern will begin setting up the laboratory in the two locations, with a focus on personnel, infrastructure and data curation.
They will launch a pilot project in the first stage and then make efforts on commercialization, with the aim of applying AI technology in medical scenarios.
“It is a privilege and honor to work along with Malong to develop state-of-the-art AI technology for neuroimaging applications,” said Mauricio Reyes, head of the Medical Image Analysis group at the Institute for Surgical Technology and Biomechanics at the University of Bern.
“The synergies we have identified and the interdisciplinary team we want to set up have remarkable potential.”
Huang Dinglong, co-founder and chief executive officer of Malong Technologies, said with the new joint lab, “we take a major step toward realizing our dream of bringing AI benefits to everyone”.
The partnership, which was formed on the sidelines of China Hi-Tech Fair 2018, is part of efforts by Shenzhen and Bern to deepen their relations. The two established the sister-city relations in 2015.
The China Hi-Tech Fair 2018, held in Shenzhen, lasts from November 14 to 18.